Patient Care
We deliver high-quality care with innovation and empathy.
We deliver high-quality care with innovation and empathy.
PRACTICE SUPPORT
Products
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Insights
Our Company
More
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Chief Financial Officer
Jim Spellmire has extensive financial management experience in chief financial officer and controller roles, including the management of treasury, financial planning and analysis, and accounting functions in a broad range of industries. He joined National Cardiovascular Partners in January 2018 in the position of chief financial officer.
Prior to joining NCP, Jim held financial management positions in Fortune 500 companies including Unisys and Delta Airlines as well as interim financial managements roles at Mills Fleet Farm, Schwing America, and Canterbury Park Holdings. While at NCP, he has reorganized the accounting and FP&A functions to improve efficiencies through the re-engineering of processes.
Jim has a bachelor of business administration in finance and a master of business administration from Florida Atlantic University in Boca Raton, Florida.
© 2006-2023 Fresenius Medical Care. All Rights Reserved.